Pharmaceutical Lobbying Sees Significant Increase; Bristol-Myers Forms New Partnership in China
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
Editorial Staff 28 days ago